Abstract
Background
For the interpretation of concentrations of gamma-hydroxybutyrate (GHB) in post-mortem specimens, a possible increase due to post-mortem generation in the body and in vitro has to be considered. The influence of different storage conditions and the specimen type was investigated.
Method and material
Post-mortem GHB concentrations in femoral venous blood (VB), heart blood (HB), serum (S) from VB, urine (U), cerebrospinal fluid (CSF) and vitreous humour (VH) were determined by gas chromatography–mass spectrometry after derivatisation. Various storage conditions, that is 4 °C or room temperature (RT) and the addition of sodium fluoride (NaF), were compared during storage up to 30 days. Additionally, bacterial colonisation was determined by mass spectrometry fingerprinting.
Results
Twenty-six cases without involvement of exogenous GHB were examined. GHB concentrations (by specimen) at day 0 were 3.9–22.1 mg/L (VB), 6.6–33.3 mg/L (HB), < 0.5–18.1 mg/L (U), 1.1–10.4 mg/L (CSF) and 1.7–22.0 mg/L (VH). At 4 °C, concentrations increased at day 30 to 5.6–74.5 mg/L (VB), 4.6–76.5 mg/L (HB) and < 0.5–21.3 mg/L (U). At RT, concentrations rose to < 0.5–38.5 mg/L (VB), 1.2–94.6 mg/L (HB) and < 0.5–37.5 mg/L (U) at day 30. In CSF, at RT, an increase up to < 0.5–21.2 mg/L was measured, and at 4 °C, a decrease occurred (< 0.5–6.5 mg/L). GHB concentrations in VH remained stable at both temperatures (1.2–20.9 mg/L and < 0.5–26.2 mg/L). The increase of GHB in HB samples with NaF was significantly lower than that without preservation. No correlation was found between the bacterial colonisation and extent of GHB concentration changes.
Conclusion
GHB concentrations can significantly increase in post-mortem HB, VB and U samples, depending on storage time, temperature and inter-individual differences. Results in CSF, VH, S and/or specimens with NaF are less affected.
Similar content being viewed by others
References
Roth RH, Giarman NJ (1970) Natural occurrence of gamma-hydroxybutyrate in mammalian brain. Biochem Pharmacol 19:1087–1093. https://doi.org/10.1016/0006-2952(70)90370-9
Abanades S, Farré M, Segura M, Pichini S, Pastor A, Pacifici R, Pellegrini M, Rdl T (2007) Disposition of gamma-hydroxybutyric acid in conventional and nonconventional biologic fluids after single drug administration: issues in methodology and drug monitoring. Ther Drug Monit 29(1):64–70. https://doi.org/10.1097/FTD.0b013e3180307e5e
Gallimberti L, Spella MR, Soncini CA, Gessa GL (2000) Gamma-hydroxybutyric acid in the treatment of alcohol and heroin dependence. Alcohol 20(3):257–262
Corkery JM, Loi B, Claridge H, Goodair C, Corazza O, Elliott S, Schifano F (2015) Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): a literature review with a focus on UK fatalities related to non-medical use. Neurosci Biobehav Rev 53:52–78. https://doi.org/10.1016/j.neubiorev.2015.03.012
Knudsen K, Greter J, Verdicchio M (2008) High mortality rates among GHB abusers in Western Sweden. Clin Toxicol 46(3):187–192. https://doi.org/10.1080/15563650701263633
Knudsen K, Jonsson U, Abrahamsson J (2010) Twenty-three deaths with γ-hydroxybutyrate overdose in western Sweden between 2000 and 2007. Acta Anaesthesiol Scand 54(8):987–992. https://doi.org/10.1111/j.1399-6576.2010.02278.x
Carter LP, Koek W, France CP (2009) Behavioral analyses of GHB: receptor mechanisms. Pharmacol Ther 121(1):100–114. https://doi.org/10.1016/j.pharmthera.2008.10.003
Kintz P, Goullé J-P, Cirimele V, Ludes B (2001) Window of detection of γ-hydroxybutyrate in blood and saliva. Clin Chem 47(11):2033–2034
Haller C, Thai D, Jacob Iii P, Dyer JE (2006) GHB urine concentrations after single-dose administration in humans. J Anal Toxicol 30(6):360–364
Andresen H, Sprys N, Schmoldt A, Mueller A, Iwersen-Bergmann S (2010) Gamma-hydroxybutyrate in urine and serum: additional data supporting current cut-off recommendations. Forensic Sci Int 200(1):93–99. https://doi.org/10.1016/j.forsciint.2010.03.035
Elliott SP (2003) Gamma hydroxybutyric acid (GHB) concentrations in humans and factors affecting endogenous production. Forensic Sci Int 133(1):9–16. https://doi.org/10.1016/S0379-0738(03)00043-4
Crookes CE, Faulds MC, Forrest ARW, Galloway JH (2004) A reference range for endogenous gamma-hydroxybutyrate in urine by gas chromatography-mass spectrometry. J Anal Toxicol 28(8):644–649. https://doi.org/10.1093/jat/28.8.644
Elian AA (2002) Determination of endogenous gamma-hydroxybutyric acid (GHB) levels in antemortem urine and blood. Forensic Sci Int 128(3):120–122. https://doi.org/10.1016/S0379-0738(02)00183-4
Doherty J, Hattox S, Snead OC, Roth R (1978) Identification of endogenous gamma-hydroxybutyrate in human and bovine brain and its regional distribution in human, guinea pig and rhesus monkey brain. J Pharmacol Exp Ther 207(1):130–139
Kintz P, Villain M, Cirimele V, Ludes B (2004) GHB in postmortem toxicology: discrimination between endogenous production from exposure using multiple specimens. Forensic Sci Int 143(2):177–181
Elliott S (2001) The presence of gamma-hydroxybutyric acid (GHB) in postmortem biological fluids. J Anal Toxicol 25(2):152–152. https://doi.org/10.1093/jat/25.2.152
Andresen-Streichert H, Jensen P, Kietzerow J, Schrot M, Wilke N, Vettorazzi E, Mueller A, Iwersen-Bergmann S (2015) Endogenous gamma-hydroxybutyric acid (GHB) concentrations in post-mortem specimens and further recommendation for interpretative cut-offs. Int J Legal Med 129(1):57–68. https://doi.org/10.1007/s00414-014-1051-8
Moriya F, Hashimoto Y (2005) Site-dependent production of γ-hydroxybutyric acid in the early postmortem period. Forensic Sci Int 148(2):139–142
Kugelberg FC, Holmgren A, Eklund A, Jones AW (2010) Forensic toxicology findings in deaths involving gamma-hydroxybutyrate. Int J Legal Med 124(1):1–6
LeBeau MA, Miller ML, Levine B (2001) Effect of storage temperature on endogenous GHB levels in urine. Forensic Sci Int 119(2):161–167
LeBeau MA, Montgomery MA, Morris-Kukoski C, Schaff JE, Deakin A (2007) Further evidence of in vitro production of gamma-hydroxybutyrate (GHB) in urine samples. Forensic Sci Int 169(2):152–156
Kerrigan S (2002) In vitro production of gamma-hydroxybutyrate in antemortem urine samples. J Anal Toxicol 26(8):571–574
Beránková K, Mutňanská K, Balíková M (2006) Gamma-hydroxybutyric acid stability and formation in blood and urine. Forensic Sci Int 161(2):158–162. https://doi.org/10.1016/j.forsciint.2006.01.017
Zörntlein S, Kopp A, Becker J, Kaufmann T, Röhrich J, Urban R (2012) In vitro production of GHB in blood and serum samples under various storage conditions. Forensic Sci Int 214(1):113–117
Stephens B, Coleman D, Baselt R (1999) In vitro stability of endogenous gamma-hydroxybutyrate in postmoretem blood. Journal of Forensic Science 44(1):231–231
Busardò FP, Bertol E, Vaiano F, Baglio G, Montana A, Barbera N, Zaami S, Romano G (2014) Post mortem concentrations of endogenous gamma hydroxybutyric acid (GHB) and in vitro formation in stored blood and urine samples. Forensic Sci Int 243:144–148. https://doi.org/10.1016/j.forsciint.2014.07.019
Marinetti LJ, Isenschmid DS, Hepler BR, Kanluen S (2005) Analysis of GHB and 4-methyl-GHB in postmortem matrices after long-term storage. J Anal Toxicol 29(1):41–47
Braunwarth H, Brill FHH, Hegeholz D, Hammerer P (2012) Der Einfluss der Viskosität von künstlichem Harn auf die Durchflussgeschwindigkeit in Kathetern. Der Urologe 51(3):403–408. https://doi.org/10.1007/s00120-012-2807-8
Christner M, Rohde H, Wolters M, Sobottka I, Wegscheider K, Aepfelbacher M (2010) Rapid identification of bacteria from positive blood culture bottles by use of matrix-assisted laser desorption-ionization time of flight mass spectrometry fingerprinting. J Clin Microbiol 48(5):1584–1591. https://doi.org/10.1128/jcm.01831-09
Moriya F, Hashimoto Y (2004) Endogenous γ-hydroxybutyric acid levels in postmortem blood. Legal Med 6(1):47–51
Castro AL, Tarelho S, Dias M, Reis F, Teixeira HM (2016) Comparison of endogenous GHB concentrations in blood and hair in death cases with emphasis on the post mortem interval. Int J Legal Med 130(4):959–965. https://doi.org/10.1007/s00414-016-1321-8
Busardò FP, Mannocchi G, Giorgetti R, Pellegrini M, Baglio G, Zaami S, Marinelli E, Pichini S (2017) Stability of endogenous GHB in vitreous humor vs peripheral blood in dead bodies. Forensic Sci Int 274:64–69. https://doi.org/10.1016/j.forsciint.2016.12.025
Elliott SP (2004) Further evidence for the presence of GHB in postmortem biological fluid: implications for the interpretation of findings. J Anal Toxicol 28(1):20–26. https://doi.org/10.1093/jat/28.1.20
Erdmann F, Zandt D, Auch J, Schütz H, Weiler G, Verhoff M (2006) Investigations concerning the threshold value between endogenous and exogenous GHB (liquid ecstasy). Archiv Für Kriminologie 217(5–6):129–136
Fieler EL, Coleman DE, Baselt RC (1998) γ-Hydroxybutyrate concentrations in pre- and postmortem blood and urine. Clin Chem 44(3):692–692
Castro AL, Dias M, Reis F, Teixeira HM (2014) Gamma-hydroxybutyric acid endogenous production and post-mortem behaviour—the importance of different biological matrices, cut-off reference values, sample collection and storage conditions. J Forensic Legal Med 27:17–24. https://doi.org/10.1016/j.jflm.2014.07.008
Thomsen R, Rasmussen BS, Johansen SS, Linnet K (2017) Postmortem concentrations of gamma-hydroxybutyrate (GHB) in peripheral blood and brain tissue—differentiating between postmortem formation and antemortem intake. Forensic Sci Int 272:154–158. https://doi.org/10.1016/j.forsciint.2016.12.038
Musshoff F, Madea B (2010) Cocaine and benzoylecgonine concentrations in fluorinated plasma samples of drivers under suspicion of driving under influence. Forensic Sci Int 200(1):67–72. https://doi.org/10.1016/j.forsciint.2010.03.032
Rochholz G (2018) Empfehlungen zur Asservierung von Obduktionsmaterial für forensisch-toxikologische Untersuchungen und spezielle Aspekte der Postmortem-Analytik. Toxichem Krimtech 85(1):14–34
Chen M, Andrenyak DM, Moody DE, Foltz RL (2003) Stability of plasma gamma-hydroxybutyrate determined by gas chromatography-positive ion chemical ionization-mass spectrometry. J Anal Toxicol 27(7):445–448. https://doi.org/10.1093/jat/27.7.445
Sakurada K, Kobayashi M, Iwase H, Yoshino M, Mukoyama H, Takatori T, K-i Y (2002) Production of γ-hydroxybutyric acid in postmortem liver increases with time after death. Toxicol Lett 129(3):207–217
Busardò FP, Portelli F, Montana A, Rotolo MC, Pichini S, Maresi E (2017) When a death apparently associated to sexual assault is instead a natural death due to idiopathic hypereosinophilic syndrome: the importance of gamma-hydroxybutyric acid analysis in vitreous humor. Legal Med 26:92–97. https://doi.org/10.1016/j.legalmed.2017.04.001
Elliott S, Lowe P, Symonds A (2004) The possible influence of micro-organisms and putrefaction in the production of GHB in post-mortem biological fluid. Forensic Sci Int 139(2):183–190. https://doi.org/10.1016/j.forsciint.2003.10.018
Kintz P, Villain M, Pélissier A-L, Cirimele V, Leonetti G (2005) Unusually high concentrations in a fatal GHB case. J Anal Toxicol 29(6):582–585
Mazarr-Proo S, Kerrigan S (2005) Distribution of GHB in tissues and fluids following a fatal overdose. J Anal Toxicol 29(5):398–400
Mehling L-M, Johansen SS, Wang X, Doberentz E, Madea B, Hess C (2016) Drug facilitated sexual assault with lethal outcome: GHB intoxication in a six-year-old girl. Forensic Sci Int 259:e25–e31. https://doi.org/10.1016/j.forsciint.2015.12.044
Acknowledgements
We thank the toxicology team at the Institute of Legal Medicine in Hamburg for their encouragement.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kietzerow, J., Otto, B., Wilke, N. et al. The challenge of post-mortem GHB analysis: storage conditions and specimen types are both important. Int J Legal Med 134, 205–215 (2020). https://doi.org/10.1007/s00414-019-02150-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00414-019-02150-w